Vimarsana
Biggest News Aggregation in the World

Benevolent Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benevolent Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benevolent Platform Today - Breaking & Trending Today

AstraZeneca selects new heart failure target with BenevolentAI - Vimarsana News

AstraZeneca selects new heart failure target with BenevolentAI

The target was discovered leveraging the AI-driven drug discovery platform of BenevolentAI and validated by AstraZeneca.

Source: yahoo.com
BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers - Vimarsana News

BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers

Regulatory News: BenevolentAI , a leader in applying advanced AI to accelerate biopharma drug discovery, today announces positive safety data from its Phase Ia, first-in-human, clinical study of...

BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers -March 25, 2024 at 02:05 am EDT - Vimarsana News

BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers -March 25, 2024 at 02:05 am EDT

BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers London, UK, 25 March...

Leadership capability to benefit company's AI activities Labmate Online - Vimarsana News

Leadership capability to benefit company's AI activities Labmate Online

AI provider BenevolentAI has announced the appointment of Dr. Click to read more...

BenevolentAI: Shareholder Letter December 2023 -December 28, 2023 at 01:01 am EST - Vimarsana News

BenevolentAI: Shareholder Letter December 2023 -December 28, 2023 at 01:01 am EST

Regulatory News: Posted to shareholders on 27 December 2023 Dear Shareholders AI is becoming an accepted and validated approach to drug discovery and development with long term structural...